Search

Displaying results 4311 - 4320 of 6951 in total
  1. Drug

    Mannose

    go.drugbank.com/drugs/DB12907
    Investigational

    Mannose is under investigation for the basic science of IUGR and Pregnancy.

  2. Drug

    Hypericin

    go.drugbank.com/drugs/DB13014
    Investigational

    Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.

  3. Drug

    Mapracorat

    go.drugbank.com/drugs/DB12041
    Investigational

    Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.

  4. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.

  5. Drug

    Salvinorin A

    go.drugbank.com/drugs/DB12327
    Investigational

    Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.

  6. Drug

    Urapidil

    go.drugbank.com/drugs/DB12661
    Investigational

    Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.

    Categories: Serotonin Receptor Agonists, Adrenergic alpha-1 Receptor Antagonists
  7. Drug

    Fosnetupitant

    go.drugbank.com/drugs/DB14019
    ApprovedInvestigational

    the Swiss company Helsinn approved the intravenous formulation of AKYNZEO® (NEPA, a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) as an alternative treatment option for

    Categories: Substance P/Neurokinin-1 Receptor Antagonist
  8. Drug

    ROX-888

    go.drugbank.com/drugs/DB05364
    Experimental

    ROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.

  9. Drug

    Glembatumumab vedotin

    go.drugbank.com/drugs/DB05996
    Investigational

    A conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer.

  10. Drug

    Ridogrel

    go.drugbank.com/drugs/DB01207
    Experimental

    However, there currently are no clinical indications for preferential use of ridogrel over aspirin. … Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction.